IEQ CAPITAL, LLC - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.

Quarter-by-quarter ownership
IEQ CAPITAL, LLC ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$205,632
+53.6%
26,880
+50.0%
0.00%
+33.3%
Q2 2023$133,862
+12.0%
17,9200.0%0.00%0.0%
Q1 2023$119,526
-13.5%
17,9200.0%0.00%
-25.0%
Q4 2022$138,163
-27.7%
17,9200.0%0.00%
-20.0%
Q3 2022$191,00017,9200.01%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
Obvious Management Services, L.L.C. 3,985,087$42,401,000100.00%
Two Sigma Ventures, LP 903,400$9,612,000100.00%
DCVC Opportunity Fund II GP, LLC 3,951,141$42,040,00054.37%
Data Collective IV GP, LLC 5,941,120$63,214,00049.97%
MIC Capital Management UK LLP 8,451,758$89,927,00016.21%
MV Management XI, L.L.C. 1,971,908$20,981,00015.20%
ArchPoint Investors 1,116,126$11,876,0004.85%
HARVARD MANAGEMENT CO INC 1,509,254$16,058,0002.00%
PLATINUM INVESTMENT MANAGEMENT LTD 2,251,971$23,961,0001.00%
Duquesne Family Office 1,385,950$14,747,0000.84%
View complete list of RECURSION PHARMACEUTICALS IN shareholders